Literature DB >> 8782206

Intragraft angiotropic large-cell lymphoma of T cell-type in a long-term renal allograft recipient.

R P Ghorbani1, H Shokouh-Amiri, L W Gaber.   

Abstract

Chronic immune suppression is a risk for the development of post-transplantation lymphoproliferative disorders, which are frequently caused by a B-cell dyscrasia. We report a unique primary presentation of the rare angiotropic lymphoma in a kidney allograft, 18 years after transplantation. The diagnosis was made by a percutaneous allograft biopsy specimen when the recipient presented with renal dysfunction and intermittent hematuria. Immunostaining of the biopsy specimen revealed a T-cell lineage of the neoplastic cells rather than the more common B-cell source. At the time of biopsy, there was no evidence of systemic dissemination of lymphoma. The intragraft lymphoma resolved completely after chemotherapy, but the patient died 6 months later as a result of an intracerebral hemorrhage. At autopsy, intravascular lymphoma was only found in the cerebral vessels. To the authors' knowledge, this is the first report of angiotropic T-cell lymphoma in a kidney allograft. A description of the clinical, pathologic, and immunohistochemical features of this case is provided, as well as reviews of previous reports of renal angiotropic lymphoma and post-transplantation T-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782206

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  2 in total

Review 1.  Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review.

Authors:  V Costes-Martineau; C Delfour; S Obled; L Lamant; G-P Pageaux; P Baldet; P Blanc; G Delsol
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Intravascular large T-cell lymphoma: a case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression.

Authors:  Emiko Takahashi; Kazuyoshi Kajimoto; Toshiaki Fukatsu; Megumi Yoshida; Tadaaki Eimoto; Shigeo Nakamura
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.